Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake
Sharon O. Jensen-Cody, Kyle H. Flippo, Kristin E. Claflin, et al.
Cell Metabolism (2020) Vol. 32, Iss. 2, pp. 273-286.e6
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 201
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 195
Hepatokines and metabolism: Deciphering communication from the liver
Sharon O. Jensen-Cody, Matthew J. Potthoff
Molecular Metabolism (2020) Vol. 44, pp. 101138-101138
Open Access | Times Cited: 171
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 165
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
Patrycja Puchalska, Peter A. Crawford
Annual Review of Nutrition (2021) Vol. 41, Iss. 1, pp. 49-77
Open Access | Times Cited: 160
Mitochondria as Cellular and Organismal Signaling Hubs
Koning Shen, Corinne L. Pender, Raz Bar‐Ziv, et al.
Annual Review of Cell and Developmental Biology (2022) Vol. 38, Iss. 1, pp. 179-218
Closed Access | Times Cited: 108
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance
Ewa Szczepańska, Małgorzata Gietka‐Czernel
Hormone and Metabolic Research (2022) Vol. 54, Iss. 04, pp. 203-211
Open Access | Times Cited: 84
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Timothy P. Rolph, Madeline Knott, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 562-576
Closed Access | Times Cited: 32
FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota
Tingting Zhang, Wei Wang, Jiayu Li, et al.
Nature Microbiology (2025)
Closed Access | Times Cited: 3
Stress-induced FGF21 and GDF15 in obesity and obesity resistance
Susanne Keipert, Mario Ost
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 11, pp. 904-915
Closed Access | Times Cited: 94
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W. Chinn, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 46, pp. 28992-29000
Open Access | Times Cited: 79
Circadian Rhythms of the Hypothalamus: From Function to Physiology
Rachel Van Drunen, Kristin Eckel‐Mahan
Clocks & Sleep (2021) Vol. 3, Iss. 1, pp. 189-226
Open Access | Times Cited: 74
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
Emma Henriksson, Birgitte Andersen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 72
FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit
Kyle H. Flippo, Samuel A.J. Trammell, Matthew P. Gillum, et al.
Cell Metabolism (2022) Vol. 34, Iss. 2, pp. 317-328.e6
Open Access | Times Cited: 58
Normal and Pathological NRF2 Signalling in the Central Nervous System
Tony Heurtaux, David Bouvier, Alexandre Bénani, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1426-1426
Open Access | Times Cited: 45
The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44
Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21
Verónica Pena-León, Cintia Folgueira, Silvia Barja-Fernández, et al.
Nature Metabolism (2022) Vol. 4, Iss. 7, pp. 901-917
Open Access | Times Cited: 44
The potential function and clinical application of FGF21 in metabolic diseases
Zhiwei Chen, Lili Yang, Yang Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Protein appetite as an integrator in the obesity system: the protein leverage hypothesis
David Raubenheimer, Stephen J. Simpson
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1888
Open Access | Times Cited: 23
Metabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms
Xiaoyue Yang, Kangli Qiu, Yaoyao Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7621-7621
Open Access | Times Cited: 8
A gut microorganism turns the dial on sugar intake
Cécile Fayt, Nuria Morales‐Puerto, Amandine Everard
Nature Microbiology (2025)
Closed Access | Times Cited: 1
FGF19 and FGF21: In NASH we trust
Saswata Talukdar, Alexei Kharitonenkov
Molecular Metabolism (2020) Vol. 46, pp. 101152-101152
Open Access | Times Cited: 64
How does the skeletal muscle communicate with the brain in health and disease?
Alinny Rosendo Isaac, Ricardo A. S. Lima-Filho, Mychael V. Lourenco
Neuropharmacology (2021) Vol. 197, pp. 108744-108744
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top